Literature DB >> 20410484

Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses.

Jerry Y Niederkorn1, Peter W Chen, Jessamee Mellon, Christina Stevens, Elizabeth Mayhew.   

Abstract

Allergic conjunctivitis (AC) and airway hyperreactivity exacerbate corneal allograft rejection. Because AC and airway hyperreactivity are allergic diseases of mucosal tissues, we determined whether an allergic disease of a nonmucosal tissue would affect corneal allograft rejection and whether Th2 cells alone accounted for accelerated graft rejection in allergic mice. Hosts sensitized cutaneously with short ragweed pollen developed cutaneous immediate hypersensitivity but rejected corneal allografts at the same tempo and incidence as naive mice. Th2 immune deviation induced with keyhole limpet hemocyanin and IFA did not affect corneal allograft rejection. Thus, Th2 immune deviation alone does not account for the exacerbation of corneal allograft rejection that occurs in mice with AC. CD4(+) T cells from AC mice elaborated Th1 (IFN-gamma) and Th2 (IL-13) cytokines when challenged with donor alloantigens. Adoptive transfer of Th1 or Th2 cells to nude mice, from AC mice that had rejected corneal allografts, produced graft rejection in 70% and 20% of the hosts, respectively. In contrast, adoptive transfer of a combination of Th1 and Th2 cells produced 100% rejection. Administration of exogenous IFN-gamma could substitute for Th1 cells and produced 100% corneal allograft rejection in recipients of Th2 cells alone. By contrast, IFN-gamma did not significantly enhance corneal allograft rejection mediated by Th1 cells. Thus, exacerbation of corneal allograft rejection in mice with AC is associated with a mixed Th1 and Th2 alloimmune response, and the contribution of Th1 cells is through their production of IFN-gamma.

Entities:  

Mesh:

Year:  2010        PMID: 20410484      PMCID: PMC2910911          DOI: 10.4049/jimmunol.0902300

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Corneal transplantation: how successful are we?

Authors:  A Waldock; S D Cook
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes.

Authors:  J Yamada; M Yoshida; A W Taylor; J W Streilein
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis.

Authors:  Sushma Hegde; Clay Beauregard; Elizabeth Mayhew; Jerry Y Niederkorn
Journal:  Transplantation       Date:  2005-01-15       Impact factor: 4.939

4.  Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.

Authors:  Y F Yao; Y Inoue; D Miyazaki; Y Hara; Y Shimomura; Y Tano; Y Ohashi
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-02       Impact factor: 4.799

5.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 6.  The immunobiology of corneal transplantation.

Authors:  Keryn A Williams; Douglas J Coster
Journal:  Transplantation       Date:  2007-10-15       Impact factor: 4.939

7.  Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells.

Authors:  Martin E Dahl; Karim Dabbagh; Denny Liggitt; Sung Kim; David B Lewis
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

8.  STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells.

Authors:  Brendan B L Pillemer; Zengbiao Qi; Barbro Melgert; Timothy B Oriss; Prabir Ray; Anuradha Ray
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

9.  Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate.

Authors:  G Van der Veen; L Broersma; C D Dijkstra; N Van Rooijen; G Van Rij; R Van der Gaag
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-08       Impact factor: 4.799

10.  Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.

Authors:  Y He; J Mellon; R Apte; J Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-07       Impact factor: 4.799

View more
  14 in total

Review 1.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

Review 2.  Animal models of high-risk corneal transplantation: A comprehensive review.

Authors:  Rohan Bir Singh; Anna Marmalidou; Afsaneh Amouzegar; Yihe Chen; Reza Dana
Journal:  Exp Eye Res       Date:  2020-07-25       Impact factor: 3.467

3.  Protection by LPS-induced inhibitory CD11b(+) cells on corneal allograft.

Authors:  Yuping Han; Shaozhen Zhao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts.

Authors:  K Cunnusamy; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-10-01       Impact factor: 8.086

Review 5.  High-risk corneal allografts and why they lose their immune privilege.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-10

6.  Paradigm shifts in the role of CD4+ T cells in keratoplasty.

Authors:  Khrishen Cunnusamy; Peter W Chen; Jerry Y Niederkorn
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

7.  Gamma-irradiation reduces the allogenicity of donor corneas.

Authors:  William Stevenson; Sheng-Fu Cheng; Parisa Emami-Naeini; Jing Hua; Eleftherios I Paschalis; Reza Dana; Daniel R Saban
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-01       Impact factor: 4.799

Review 8.  New twists to an old story: novel concepts in the pathogenesis of allergic eye disease.

Authors:  Daniel R Saban; Virginia Calder; Chuan-Hui Kuo; Nancy J Reyes; Darlene A Dartt; Santa J Ono; Jerry Y Niederkorn
Journal:  Curr Eye Res       Date:  2013-01-02       Impact factor: 2.424

9.  Immunology of Corneal Allografts: Insights from Animal Models.

Authors:  Jerry Y Niederkorn
Journal:  J Clin Exp Ophthalmol       Date:  2015-06

Review 10.  Corneal transplantation and immune privilege.

Authors:  Jerry Y Niederkorn
Journal:  Int Rev Immunol       Date:  2013-02       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.